The health benefits of chia seeds have been well publicised, but health and internet experts are urging people to not believe ...

Chia seeds also contain calcium and phosphorus as well as magnesium. All three of these minerals have been known to help support optimal bone health. Research shows that getting enough of these ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. The launch this week of an oral pill version of Wegovy ...

If you’re looking to create a healthier lifestyle, look no further than the power of running. Movement makes up a portion of the weight loss puzzle, and with our new Running for Weight Loss program, ...

Share on Pinterest The Food and Drug Administration (FDA) recently approved a tablet version of the GLP-1 drug Wegovy for weight loss. Image courtesy of Novo Nordisk Novo Nordisk officials said a new ...

A pill form of weight-loss drug Wegovy, manufactured by Danish drugmaker Novo Nordisk, is now available in the U.S., giving Americans access to an oral medication to treat obesity. The starting dose ...

PHILADELPHIA — The Eagles finished off their season Sunday night with a 24-17 loss to the Washington Commanders that prevented them from moving up to the second seed in the NFC. Coach Nick Sirianni’s ...

A pill version of the blockbuster weight-loss medication Wegovy is rolling out in the U.S., and people are already actively navigating prescriptions. Experts say that a pill version of the high-demand ...

Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including Wegovy and Zepbound are expected to be easier to access and afford. And new ...

Running is a popular form of exercise for people looking to lose weight. And there’s good reason for that: It’s a really efficient way to expend energy, which is helpful when you’re striving to burn ...

GLP-1 medications have dominated the weight-loss landscape this year — but some older Americans are reportedly kicking the trend to the curb. A study published in JAMA in January 2025 — which looked ...